EBI-907

CAT: 0931-MF-0144812-01Size: 25 mgDry Ice: NoHazardous: No
CAT#:0931-MF-0144812-01Size:25 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
CAS Number
1581764-31-9
Target
Raf|||Others
Related Pathways
MAPK|||Others
Bioactivity
EBI-907 is a highly potent and orally efficacious B-RafV600E inhibitor. EBI-907 displays a low single-digit nanomolar activity (IC50 = 4.9 nM), which is >10-fold more potent than Vemurafenib (IC50 = 59 nM) . EBI-907 also exhibits high potency in selectively inhibiting the proliferation of BRAF (V600E) -dependent cell lines (A375 and Colo205) and cellular Erk phosporylation, with superior activity to Vemurafenib. EBI-907, displaying potent activity against a number of important oncogenic kinases including BRK, FGFR1, c-Kit, and PDGFRb.
Smiles
O(C)C1=CC2=C3C(=NN=C3NC=C2C=C1C4=C(Cl)C(NS(CCCF)(=O)=O)=CC=C4F)C5CC5
Molecular Formula
C23H21ClF2N4O3S
Molecular Weight
506.95
Shipping Conditions
Cool pack
Storage Temperature
-20°C

Related Products

CatalogName
MF-0018243-01JTE-907
MF-0145089-01CUDC-907 mesylate
MF-0006127-01MK-1-907
MF-0100844-01EBI-031
MF-0032781-01EBI-1051
MF-0032782-01EBI-2511
MF-0013889-011-EBIO
MF-0073402-01Anti-EBI3 Antibody (9P551)

Alternative Products

CatalogName
MBS5812965EBI-907
M16553-01XEN-907
MBS6066917-01CUDC-907
255569-01JTE 907
530625JTE-907
M12747-01EBI-1051
B2433-5EBI-2511

Popular Products